ORTHOFIX MEDICAL INC (OFIX)
Health Care · orthopedic devices and spine fixation · NASDAQ
Orthofix develops and distributes orthopedic and spine fixation devices for trauma, fracture care, and bone reconstruction across global surgical markets.
What ORTHOFIX MEDICAL INC does
Orthofix Medical is a medical device company that develops, manufactures, and markets orthopedic and spine care products used in surgical and non-surgical treatment of musculoskeletal conditions. The company designs and distributes orthopedic fixation devices, biologics, and related instruments for fracture care, spine fusion, and bone reconstruction. Orthofix operates through multiple product lines and sales channels serving surgeons, hospitals, and healthcare providers globally.
Themes: ["orthopedic devices / trauma","spine surgery","bone health","musculoskeletal care"]
Fundamentals
- Price$11.48 as of 2026-07-09 close
- Market cap$462M as of 2026-07-10
- 1-year return+1.7% as of 2026-07-09 close
- Net margin-7.3% as of 2026-07-10
- Gross margin+70.8% as of 2026-07-10
- ROE-13.4% as of 2026-07-10
- Debt / equity0.54 as of 2026-07-10
- Revenue growth (YoY)+2.6% as of 2026-07-10
- Revenue CAGR (3y)+21.3% SEC XBRL
- Beta0.71 as of 2026-07-10
Key risks (from latest filing)
["Integration and synergy realization challenges from legacy business combinations","Intense competition and risk of new competitor products making current offerings non-competitive or obsolete","Healthcare consolidation and group purchasing organization exclusion could reduce market access and drive price concessions"]
Competitors & peers
- Stryker (SYK)
- Zimmer Biomet (ZBH)
- DePuy Synthes (Johnson & Johnson subsidiary)
- Medtronic (MDT)
- NuVasive (NUVA)
- Globus Medical (GMED)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.